Learn about peripheral artery disease and its effects on blood flow. We explain symptoms, risk factors, and treatments to ...

ON THIS ASSUMED LINK. WELL, IN TONIGHT’S WOMAN’S DOCTOR, IF YOU’RE HAVING SOME UNEXPLAINED LEG PAIN, YOU MAY WANT TO ASK YOUR DOCTOR ABOUT PERIPHERAL ARTERY DISEASE OR PAD PAD IN YOUR LOWER BODY. IS ...

In early 2021, Tony Black’s left foot suddenly started to swell after a severe bout of COVID-19. He went to an urgent care clinic and was told it was likely gout. But with his foot swelling to the ...

For decades, treatment of peripheral artery disease has focused almost exclusively on restoring blood flow. Now, new research ...

Leading medical societies dedicated to improving vascular health urge patients, providers, and policymakers to act through the Get a Pulse on PAD Campaign Society for Cardiovascular Angiography and ...

BACKGROUND: Peripheral artery disease (PAD) and its severe form, chronic limb-threatening ischemia (CLTI), significantly impair blood flow to the lower extremities, affecting millions of adults ...

A recent study published in the PLOS One Journal explored sex differences in how major risk factors relate to hospitalization or mortality due to incident peripheral artery disease (PAD) and whether ...

Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care from a multispecialty team, are essential to help prevent amputation and other cardiovascular ...

Dr. Dua, a vascular surgeon, is co-director of the Peripheral Artery Disease Center and Limb Evaluation and Preservation Program at Massachusetts General Hospital. In the fall of 2021, a soft-spoken ...

Liraglutide (Victoza), a type 2 diabetes drug, may help prevent peripheral artery disease (PAD) progression, the small, open-label STARDUST trial suggested. Over 6 months, adults with type 2 diabetes ...

"Our findings highlight the clinical importance of focusing on total disease burden, rather than first events, and the need for long-term preventive strategies in high-risk patients."—Michael Szarek, ...

The peripheral vascular device market will rise from $10.4B in 2025 to $14.8B by 2032, driven by drug‑coated balloons, ...